Pacira BioSciences (PCRX) EBT Margin Growth (3y) (2013 - 2026)
Pacira BioSciences (PCRX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | -2,101.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,101.00 |
| Mar 31, 2026 | 1,933.00 |
| Dec 31, 2025 | -338.00 |
| Sep 30, 2025 | 407.00 |
| Jun 30, 2025 | -1,405.00 |
| Mar 31, 2025 | 54.00 |
| Dec 31, 2024 | 1,753.00 |
| Sep 30, 2024 | -10,134.00 |
| Jun 30, 2024 | 163.00 |
| Mar 31, 2024 | -253.00 |
| Dec 31, 2023 | 891.00 |
| Sep 30, 2023 | 489.00 |
| Jun 30, 2023 | 3,202.00 |
| Mar 31, 2023 | -2,461.00 |
| Dec 31, 2022 | 656.00 |
| Sep 30, 2022 | 679.00 |
| Jun 30, 2022 | 1,189.00 |
| Mar 31, 2022 | 737.00 |
| Dec 31, 2021 | -1,264.00 |
| Sep 30, 2021 | 1,981.00 |